TrivarX Limited (ASX: TRI)
Health Care · Health Care Technology · AU
AU$0.02
+7.14% today · +50.0% 1Y
TrivarX Limited (ASX: TRI) operates in the Health Care Technology industry within the Health Care sector. The company is valued at $12.40M and employs 6 people.
Over the last twelve months the share price has gained 50.0%, trading between 0.01 and 0.04.
Tweenvest scores TrivarX Limited across four factors: quality 37/100, value 68/100. Its strongest factor is value.
TRI price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $12.40M
- Revenue (TTM)
- $-63.61K
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.84
- 52-week high
- AU$0.04
- 52-week low
- AU$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 1.15B
- Employees
- 6
- Next earnings
- —
About TrivarX Limited
Operating as a health technology enterprise, TrivarX Limited specializes in crafting artificial intelligence-driven, scientifically validated instruments designed for the assessment and identification of behavioral health disorders. Its market presence extends across Australia and the United States. The company delivers mental well-being provisions tailored for corporate clients through its enterprise health offerings, concurrently developing solutions for medical service providers. Established in 1987, the entity was formerly known as Medibio Limited until its rebranding as TrivarX Limited in October 2023. Its principal place of business is situated in Mount Lawley, Australia.
- ISIN
- AU0000300196
- Founded
- 1987
- Listed since
- Jan 28, 2001
- Exchange
- Australian Securities Exchange
- Currency
- AUD
Other Health Care Technology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Veeva Systems Inc.NYSE: VEEV | $40.27B | $247.90 | -1.05% |
| Pro Medicus LimitedASX: PME | $14.35B | AU$191.60 | -6.99% |
| M3, Inc.TSE: 2413 | $7.17B | ¥1,708.00 | -2.43% |
| Sectra AB (publ)OM: SECT B | $5.66B | Skr278.00 | -1.35% |
| Waystar Holding Corp.NasdaqGS: WAY | $4.80B | $25.01 | +0.68% |
| Doximity, Inc.NYSE: DOCS | $4.51B | $25.33 | -2.35% |
| HeartFlow, Inc.NasdaqGS: HTFL | $3.66B | $49.75 | +18.23% |
| Inventurus Knowledge Solutions LimitedNSEI: IKS | $3.30B | Rs1,840.00 | +6.43% |
Figures last refreshed Aug 18, 2026.